Healthcare provider profile · identity verified

Sharon Khan Lepak, DO

Family Practice · STUART, FL · NPI 1700875127

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	810	266
Amlodipine Besylate	Amlodipine Besylate	728	221
Levothyroxine Sodium	Levothyroxine Sodium	619	189
Atorvastatin Calcium	Atorvastatin Calcium	527	169
Lisinopril	Lisinopril	437	131
Montelukast Sodium	Montelukast Sodium	433	168
Losartan Potassium	Losartan Potassium	393	120
Pantoprazole Sodium	Pantoprazole Sodium	256	85
Omeprazole	Omeprazole	249	73
Metformin Hcl	Metformin Hcl	223	75
Hydrochlorothiazide	Hydrochlorothiazide	222	72
Trazodone Hcl	Trazodone Hcl	194	64
Metoprolol Succinate	Metoprolol Succinate	186	60
Pravastatin Sodium	Pravastatin Sodium	166	49
Gabapentin	Gabapentin	163	60
Sertraline Hcl	Sertraline Hcl	163	57
Simvastatin	Simvastatin	163	50
Alprazolam	Alprazolam	159	54
Escitalopram Oxalate	Escitalopram Oxalate	151	46
Buspirone Hcl	Buspirone Hcl	143	49
Ezetimibe	Ezetimibe	142	47
Famotidine	Famotidine	141	52
Metoprolol Tartrate	Metoprolol Tartrate	134	36
Synthroid	Levothyroxine Sodium	132	37
Zolpidem Tartrate	Zolpidem Tartrate	110	24
Atenolol	Atenolol	102	32
Duloxetine Hcl	Duloxetine Hcl	101	28
Fluticasone Propionate	Fluticasone Propionate	100	42
Baclofen	Baclofen	94	45
Citalopram Hbr	Citalopram Hydrobromide	94	28
Furosemide	Furosemide	91	31
Olmesartan Medoxomil	Olmesartan Medoxomil	90	28
Allopurinol	Allopurinol	89	26
Potassium Chloride	Potassium Chloride	85	35
Albuterol Sulfate Hfa	Albuterol Sulfate	81	32
Tamsulosin Hcl	Tamsulosin Hcl	75	27
Tramadol Hcl	Tramadol Hcl	75	20
Prednisone	Prednisone	67	63
Glimepiride	Glimepiride	63	23
Mirtazapine	Mirtazapine	59	17
Ozempic	Semaglutide	59	11
Fenofibrate	Fenofibrate Nanocrystallized	55	13
Carvedilol	Carvedilol	54	16
Bupropion Hcl Sr	Bupropion Hcl	53	18
Fluoxetine Hcl	Fluoxetine Hcl	52	15
Venlafaxine Hcl Er	Venlafaxine Hcl	51	14
Clonazepam	Clonazepam	48	suppressed
Metformin Hcl Er	Metformin Hcl	48	20
Valsartan	Valsartan	47	14
Januvia	Sitagliptin Phosphate	46	15
Meloxicam	Meloxicam	46	20
Eliquis	Apixaban	45	15
Valacyclovir	Valacyclovir Hcl	43	24
Clopidogrel	Clopidogrel Bisulfate	41	14
Celecoxib	Celecoxib	39	12
Lorazepam	Lorazepam	38	17
Paroxetine Hcl	Paroxetine Hcl	37	12
Bupropion Xl	Bupropion Hcl	36	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	35	18
Irbesartan	Irbesartan	35	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Lovastatin	Lovastatin	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	27	suppressed
Rybelsus	Semaglutide	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Spironolactone	Spironolactone	25	suppressed
Amoxicillin	Amoxicillin	24	20
Azithromycin	Azithromycin	24	24
Finasteride	Finasteride	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Sildenafil Citrate	Sildenafil Citrate	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	22
Vitamin D2	Ergocalciferol (Vitamin D2)	23	11
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Trintellix	Vortioxetine Hydrobromide	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	11
Hydroxyzine Hcl	Hydroxyzine Hcl	18	12
Jantoven	Warfarin Sodium	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Raloxifene Hcl	Raloxifene Hcl	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Diazepam	Diazepam	17	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Cephalexin	Cephalexin	16	15
Chlorthalidone	Chlorthalidone	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Temazepam	Temazepam	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fluconazole	Fluconazole	13	13
Nifedipine Er	Nifedipine	13	suppressed
Ramipril	Ramipril	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	12
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error